AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
Innovative North German oncology laboratory and generics developer AqVida has moved a significant step closer to a pioneering launch of generic Sunitinib with a successful bioequivalence (BE) study.
AqVida celebrates successful CPhI Madrid show
AqVida crowns innovative first decade with robotic filling breakthrough
AqVida joins European generics pioneers with Sunitinib development